This event was rescheduled from October 15, 2025 at 12pm EST to October 22, 2025.
For many biomedical innovators, design controls can feel like a maze of regulations standing between breakthrough ideas and real-world impact. But what if they’re not a barrier, but a blueprint? From idea to creating a startup to commercialization of the device, flexible/scalable Design Controls can drive patient confidence and engineering excellence while meeting regulatory requirements. Jason Glithero has over 20 years of medical device experience in using and upgrading design control systems that lead to agile and faster design development scenarios. This session will help you rethink compliance as a strategic advantage.
The Bench2Market Talks series is created to provide commercialization guidance to the university research community. For more details on the series, visit our website at https://biolocity.gatech.edu/news-and-events/b2m-talks/.
Powered by WordPress & Theme by Anders Norén
You must be logged in to post a comment.